RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+17.9%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.07B
AUM Growth
+$1.07B
(+25%)
Cap. Flow
+$126M
Cap. Flow
% of AUM
11.81%
Top 10 Holdings %
Top 10 Hldgs %
29.29%
Holding
121
New
28
Increased
49
Reduced
15
Closed
16
Top Buys
| 1 |
Pfizer
PFE
|
$26.4M |
| 2 |
Bausch Health
BHC
|
$18.2M |
| 3 |
Travere Therapeutics
TVTX
|
$16.8M |
| 4 |
Eli Lilly
LLY
|
$16.7M |
| 5 |
RDUS
Radius Health, Inc.
RDUS
|
$16.5M |
Top Sells
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$30.2M |
| 2 |
Merck
MRK
|
$25.6M |
| 3 |
STJ
St Jude Medical
STJ
|
$21.8M |
| 4 |
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
|
$18.6M |
| 5 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$10.3M |
Sector Composition
| 1 | Healthcare | 75.22% |
| 2 | Financials | 1.56% |
| 3 | Industrials | 0.97% |
| 4 | Technology | 0.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Medtronic
MDT
$119B
| $44.6M | 4.17% | 572,300 +22,300 | +4% | +$1.74M |
|
2
AbbVie
ABBV
$372B
| $35.1M | 3.29% | 600,000 +20,000 | +3% | +$1.17M |
|
3
McKesson
MCK
$85.4B
| $33.7M | 3.15% | 149,000 +9,250 | +7% | +$2.09M |
|
|
AGN
4
DELISTED
Allergan plc
AGN
| $33.5M | 3.13% | 112,500 +24,500 | +28% | +$7.29M |
|
5
HCA Healthcare
HCA
$94.5B
| $31.8M | 2.97% | 422,500 +14,500 | +4% | +$1.09M |
|
|
6
Bausch Health
BHC
$2.74B
| $30.8M | 2.88% | 155,000 +91,750 | +145% | +$18.2M |
|
|
7
Pfizer
PFE
$141B
| $26.4M | 2.47% | +760,000 | New | +$26.4M |
|
8
Amgen
AMGN
$155B
| $26.2M | 2.45% | 164,000 +3,000 | +2% | +$480K |
|
9
Acadia Healthcare
ACHC
$2.12B
| $26M | 2.43% | 362,500 +32,750 | +10% | +$2.34M |
|
10
Gilead Sciences
GILD
$140B
| $25M | 2.34% | 255,000 | – | – |
|
|
PCYC
11
DELISTED
PHARMACYCLICS INC
PCYC
| $22.5M | 2.11% | 88,000 -500 | -0.6% | -$128K |
|
|
CELG
12
DELISTED
Celgene Corp
CELG
| $22.4M | 2.1% | 194,500 +1,500 | +0.8% | +$173K |
|
|
EVHC
13
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $21.9M | 2.04% | 570,000 +255,000 | +81% | +$9.78M |
|
|
THOR
14
DELISTED
THORATEC CORPORATION
THOR
| $21.6M | 2.02% | 515,000 -18,500 | -3% | -$775K |
|
15
Humana
HUM
$36.5B
| $19.1M | 1.79% | 107,500 +11,250 | +12% | +$2M |
|
|
ALXN
16
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $18.8M | 1.75% | 108,250 +15,750 | +17% | +$2.73M |
|
|
TMH
17
DELISTED
Team Health Holdings Inc
TMH
| $18.2M | 1.7% | 311,000 +44,500 | +17% | +$2.6M |
|
|
TRNX
18
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $17.3M | 1.62% | 660,000 +287,500 | +77% | +$7.54M |
|
19
CVS Health
CVS
$92.8B
| $16.9M | 1.58% | 164,000 +14,000 | +9% | +$1.44M |
|
|
20
Travere Therapeutics
TVTX
$1.56B
| $16.8M | 1.57% | +700,000 | New | +$16.8M |
|
|
21
Eli Lilly
LLY
$657B
| $16.7M | 1.56% | +230,000 | New | +$16.7M |
|
|
AET
22
DELISTED
Aetna Inc
AET
| $16.7M | 1.56% | 156,500 +25,500 | +19% | +$2.72M |
|
|
RDUS
23
DELISTED
Radius Health, Inc.
RDUS
| $16.5M | 1.54% | +400,000 | New | +$16.5M |
|
24
Cigna
CI
$80.3B
| $15.8M | 1.48% | 122,000 +29,000 | +31% | +$3.75M |
|
25
Biogen
BIIB
$19.4B
| $15.6M | 1.46% | 37,000 -8,500 | -19% | -$3.59M |
|